RWJ-51204 | Interleukin Related interleukin-related.com

Product Name :
RWJ-51204

Search keywords :
RWJ-51204

drugId :
null

Target Vo:
Gamma-aminobutyric acid A receptor

Target Vo Short Name :
GABAAR

Moa_Name:
Gamma-aminobutyric acid A receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Anxiety

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AMPK alpha 2 Antibody (YA833)
xCT Antibody (YA006)
ATF6 Antibody (YA604): ATF6 Antibody (YA604) is a non-conjugated and Rabbit origined monoclonal antibody about 75 kDa, targeting to ATF6. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts